#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Adrenogenital syndrome Hereditary angioedema Glomerulonephritis membranoproliferative Herpes simplex Oesophageal carcinoma Neoplasm Synovial sarcoma recurrent Muscular dystrophy Frontotemporal dementia Aspergillus infection Plasma cell myeloma Familial amyotrophic lateral sclerosis Neuronal ceroid lipofuscinosis Postprandial hypoglycaemia CDKL5 deficiency disorder More trials…

    Learn about Rare Diseases

    Hereditary neuropathic amyloidosis Cystic fibrosis – Basic Information Mucopolysaccharidosis – Basic Information Hereditary optic atrophy – Treatment Shprintzen-Goldberg syndrome – Trials in Disease Hereditary ataxia – Diagnostics Sjogren’s syndrome – Basic Information Synovial sarcoma – Diagnostics Cholangitis sclerosing – Life with Disease Familial haemophagocytic lymphohistiocytosis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dactinomycin Zinc Oxide Tozorakimab Felzartamab Ciclosporin Mk-1167 Entinostat Azd8421 Inclisiran Sodium LUXDEGALUTAMIDE GSKVX000000030825 Lutetium (177Lu) Edotreotide STREPTOCOCCUS VIRIDANS Pyridoxine Alglucosidase Alfa ULIXERTINIB Taurine ICEF15 Gadoteric Acid N-Tec More therapies…

    Learn about Your Condition

    Endometrial cancer metastatic Senile dementia Sleep disorder Neutropenia Vulvovaginal pruritus Laryngeal cancer stage III Albright's disease Meningioma Abortion threatened Precocious puberty Adenocarcinoma gastric EGFR gene mutation Hepatobiliary cancer Pulmonary sarcoidosis Cholangitis sclerosing More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. CHU Croix Rousse-Lyon

CHU Croix Rousse-Lyon

103 Grande Rue De La Croix Rousse, Lyon, 69317, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Efinopegdutide and Semaglutide for Adults with Non-Alcoholic Steatohepatitis (NASH) Before Cirrhosis

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Efinopegdutide
    • Semaglutide
    Austria Belgium Czechia France Hungary Italy +2

  • Study on the Effectiveness and Safety of Aflibercept for Patients with Vision Loss Due to Macular Edema from Retinal Vein Blockage

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Macular oedema
    • Retinal vein occlusion
    Investigated Drugs:
    • Fluorescein Sodium
    • Aflibercept
    Austria Bulgaria Czechia Estonia France Germany +8

  • Study on Azithromycin for Treating Chronic Sinusitis in Adults

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Chronic sinusitis
    • Sinusitis bacterial
    Investigated Drugs:
    • Azithromycin
    France

  • Study on Atezolizumab, Bevacizumab, and Chemotherapy for Patients with Advanced Cervical Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    France Germany Italy Norway Spain Sweden

  • Study on Reducing Asthma Medication with Tezepelumab in Patients Aged 12 to 80 with Severe Asthma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Tezepelumab
    Belgium Bulgaria Denmark France Germany Italy +1

  • Study on Durvalumab for Patients with Completely Removed Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Durvalumab
    Bulgaria France Hungary Italy The Netherlands Poland +2
Previous Page
1 … 10 11 12

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!